Literature DB >> 6812143

The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects.

D S Charney, G R Heninger, J F Reinhard, D E Sternberg, K M Hafstead.   

Abstract

In order to assess the effects of increased central nervous system serotonergic function in humans on prolactin (PRL), growth hormone (GH) and mood, intravenous L-tryptophan (TRP) was administered to ten healthy subjects. The TRP infusion induced robust increases in PRL in all ten subjects. A significant increase in GH concentration was also observed, although the response was more variable. The subjects reported feeling significantly more high, mellow, and drowsy following the TRP infusion in comparison to placebo. These findings indicate an important role for serotonin in PRL and GH secretion, as well as in mood regulation. The intravenous TRP challenge may be of use in the study of serotonergic function in a variety of neurologic and psychiatric diseases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812143     DOI: 10.1007/bf00464569

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  59 in total

1.  Effect of L-tryptophan and restraint stress on hypothalmic and brain serotonin turnover, and pituitary TSH and prolactin release in rats.

Authors:  G P Mueller; C P Twohy; H T Chen; J P Advis; J Meites
Journal:  Life Sci       Date:  1976-04-01       Impact factor: 5.037

2.  Central-nervous-system effects of ingestin of L-tryptophan by normal subjects.

Authors:  B SMITH; D J PROCKOP
Journal:  N Engl J Med       Date:  1962-12-27       Impact factor: 91.245

3.  Lack of effects of L-tryptophan on basal and TRH-stimulated TSH and prolactin levels.

Authors:  J Faber; C Hagen; C Kirkegaard; U B Lauridsen; S E Møller
Journal:  Psychoneuroendocrinology       Date:  1977-10       Impact factor: 4.905

4.  Release of ( 3 H)dopamine by L-5-hydroxytryptophan.

Authors:  L K Ng; T N Chase; R W Colburn; I J Kopin
Journal:  Brain Res       Date:  1972-10-27       Impact factor: 3.252

5.  Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses.

Authors:  C A Birge; L S Jacobs; C T Hammer; W H Daughaday
Journal:  Endocrinology       Date:  1970-01       Impact factor: 4.736

6.  Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.

Authors:  I Lancranjan; A Wirz-Justice; W Pühringer; E Del Pozo
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

Review 7.  Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine.

Authors:  A R Green; D G Grahame-Smith
Journal:  Nature       Date:  1976-04-08       Impact factor: 49.962

8.  L-tryptophan treatment and the episodic secretion of pituitary hormones and cortisol.

Authors:  M T Hyyppä; T Jolma; J Liira; V A Långvik; O Kytömäki
Journal:  Psychoneuroendocrinology       Date:  1979-01       Impact factor: 4.905

9.  The acute effects of oral (--)-tryptophan in human subjects.

Authors:  M H Greenwood; M H Lader; B D Kantameneni; G Curzon
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

10.  Absent growth hormone response to L-tryptophan in acromegaly.

Authors:  A R Glass; M Schaaf; R C Dimond
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

View more
  17 in total

1.  The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.

Authors:  P W Glue; P J Cowen; D J Nutt; T Kolakowska; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects.

Authors:  A J Cleare; A J Bond
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

4.  Hormonal and behavioral effects associated with intravenous L-tryptophan administration.

Authors:  A Winokur; N D Lindberg; I Lucki; J Phillips; J D Amsterdam
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Neuroendocrine effects of L-tryptophan and dexamethasone.

Authors:  L Träskman-Bendz; R F Haskett; A P Zis
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.

Authors:  M Koulu; M Scheinin; A Kaarttinen; J Kallio; K Pyykkö; J Vuorinen; R H Zimmer
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

Review 7.  5HT drugs in animal models of anxiety.

Authors:  S L Handley; J W McBlane
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan.

Authors:  C E Smith; C J Ware; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 9.  CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.

Authors:  W P Koella
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation.

Authors:  J F Deakin; I Pennell; A J Upadhyaya; R Lofthouse
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.